We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical, biological and histological characteristics of bullous pemphigoid associated with anti‐PD‐1/PD‐L1 therapy: A national retrospective study.
- Authors
Juzot, C.; Sibaud, V.; Amatore, F.; Mansard, S.; Seta, V.; Jeudy, G.; Pham‐Ledard, A.; Benzaquen, M.; Peuvrel, L.; Le Corre, Y.; Lesage, C.; Viguier, M.; Baroudjian, B.; Dréno, B.; Quéreux, G.
- Abstract
Clinical, biological and histological characteristics of bullous pemphigoid associated with anti-PD-1/PD-L1 therapy: A national retrospective study Immune checkpoint inhibitors (ICI), most commonly anti-programmed cell death 1 (PD-1) and anti-programmed cell death ligand 1 (PD-L1) therapies, have revolutionized the treatment of many cancers. We thank Dr C-J. Clerc (Niort), Dr E. Funck-Brentano (Paris), Dr D. Giacchero (Nice), Pr L. Mortier (Lille), Dr M. Dinulescu (Rennes), Pr L. Boussemart (Nantes), Pr L. Machet (Tours), Dr S. Duvert-Lehembre (Dunkerque), Dr A. Viarnaud (Paris), Dr C. Joachim (Amiens), Dr C. Bara (Le Mans), Dr E. Baubion (Fort de France), Dr B. Bergeret (Nîmes), Dr F. Brunet-Possenti (Paris), Dr S. Debarbieux (Lyon), Dr V. Hebert (Rouen), Pr Grange (Reims), Dr M-P. Konstantinou (Toulouse), Dr A. Marzouki-Zerouali (Nancy), Dr J. Moreau-Huguen (Lorient), Dr C. Phan (Argenteuil), Dr I. Templier (Grenoble), Dr P. Celerier (la Rochelle), Pr F. Aubin (Besançon), P. Modiano (Lille), Dr L. Dousset (Bordeaux), Dr J. Bonini (Bordeaux) for providing us patient data and for their assistance in the preparation of the manuscript.
- Subjects
BULLOUS pemphigoid; IMMUNE checkpoint proteins; PHYSICIANS
- Publication
Journal of the European Academy of Dermatology & Venereology, 2021, Vol 35, Issue 8, pe511
- ISSN
0926-9959
- Publication type
Article
- DOI
10.1111/jdv.17253